Choosing a treatment plan for a patient with colorectal cancer is complicated, says Cathy Eng, professor and director, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center.
Typically, many physicians — a pathologist, radiologist, radiation oncologist, surgeon and more — will weigh in on any given intervention outside of chemotherapy.
In the case of chemotherapy, Eng says, the type of chemotherapy matters as well as the administration. Both factors can have an effect on a patient’s work and social life.
Patients with metastatic disease will typically not undergo surgery. Because of this, Eng says, both the patient and physician need to look at colorectal cancer as a chronic illness.
“[Y]ou’re just going to have to adjust yourself to understanding that there are going to be some highs and lows of receiving treatment,” Eng says. “And unfortunately that’s the reality.”
The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer
February 16th 2023Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Listen
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Listen